Skip to main content

Omicron BQ variants resistant to antibody treatments are quickly becoming dominant in U.S.

Omicron subvariants BQ.1 and BQ.1.1 now make up 44% of new Covid cases, compared with 32% last week, according to CDC data.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.